CBIO
Crescent Biopharma
CBIO
CBIO
32 hedge funds and large institutions have $114M invested in Crescent Biopharma in 2014 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less capital invested
Capital invested by funds: $230M → $114M (-$116M)
Holders
32
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.5M | |
| 2 | +$366K | |
| 3 | +$291K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$285K |
| 5 |
MSA
Mason Street Advisors
Milwaukee,
Wisconsin
|
+$203K |
Top Sellers
| 1 | -$1.73M | |
| 2 | -$1.66M | |
| 3 | -$1.49M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.18M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.06M |